Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

The combination therapy was effective and well-tolerated, especially in young patients.

Ritlecitinib can help about 14,000 people with severe hair loss.

Ritlecitinib is safe and may effectively treat alopecia areata.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Methotrexate plus prednisolone had the fewest serious side effects.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Alopecia can be caused by multicentric reticulohistiocytosis.

Upadacitinib effectively treats psoriasis and lichen planus together.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Co-trimoxazole successfully treated a girl with multiple autoimmune symptoms.

Talquetamab may cause hair loss and skin issues.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.